Medpace Holdings, Inc.
MEDP
$419.75
$2.460.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.26% | 7.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.26% | 7.36% | |||
| Cost of Revenue | 8.85% | -2.25% | |||
| Gross Profit | -3.41% | 11.13% | |||
| SG&A Expenses | 6.68% | -6.58% | |||
| Depreciation & Amortization | -3.16% | 1.16% | |||
| Other Operating Expenses | -2.80% | 16.03% | |||
| Total Operating Expenses | 1.79% | 7.16% | |||
| Operating Income | -7.68% | 8.08% | |||
| Income Before Tax | -5.89% | 9.80% | |||
| Income Tax Expenses | 9.31% | -31.55% | |||
| Earnings from Continuing Operations | -8.33% | 21.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.33% | 21.59% | |||
| EBIT | -7.68% | 8.08% | |||
| EBITDA | -7.48% | 7.75% | |||
| EPS Basic | -8.83% | 20.93% | |||
| Normalized Basic EPS | -6.40% | 9.20% | |||
| EPS Diluted | -8.21% | 20.80% | |||
| Normalized Diluted EPS | -5.89% | 9.24% | |||
| Average Basic Shares Outstanding | 0.54% | 0.55% | |||
| Average Diluted Shares Outstanding | -0.01% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||